申请人:Aptinyx Inc.
公开号:US20210047324A1
公开(公告)日:2021-02-18
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be useful in the treatment of conditions such as depression and related disorders as well as other disorders.